Temporary liver coating may improve safety and targeting of mRNA vaccines and cancer therapies
With the commercialization of mRNA vaccines against COVID-19, research and development into the application of mRNA in vaccines and pharmaceuticals is accelerating. In particular, it is attracting attention not only in vaccines for preventing infectious diseases but also in cance
With the commercialization of mRNA vaccines against COVID-19, research and development into the application of mRNA in vaccines and pharmaceuticals is accelerating. In particular, it is attracting attention not only in vaccines for preventing infectious diseases but also in cance This story matters for Science & Discovery readers tracking student. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. StudentNewsletter curates and briefs the science & discovery stories that matter. Our editorial policy →